IDH1 and central nervous system cancer: Another recent study suggests that 31P MRSI could in principle also detect the mutation status of the isocitrate dehydrogenase (IDH) via phospholipid metabolites (7), further highlighting the potential of applying 31P MRSI in patients with glioma.